02552

2.0150.98%
YZ

Yi Zhang

Senior VP of Pharma Development, Chief Medical Officer – China and Executive Director

Dr. Yi Zhang, PhD, M.D., serves as Senior Vice President of Pharma Development and Chief Medical Officer – China at Hua Medicine (Shanghai) Ltd. since August 2020 and also serves as an Executive Director since January 01, 2024. Dr. Zhang served as Senior Vice President of Clinical R&D Department at Hua Medicine (Shanghai) Ltd. since April 2018 until August 2020 and also served as its Vice President of Clinical until April 2018. Prior to joining Hua, Dr. Zhang served as the Associate Medical Director of Clinical Science at Roche Product Development group, Asia Pacific region. She served as a clinical scientist for innovative drug development in the areas of cardiovascular, metabolic and renal diseases. Prior to Roche, Dr. Zhang served as a Physician and an Associate Professor at Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine with clinical experience. Dr. Zhang was also a team leader of the molecular genetics research group at the Shanghai Institute of Hypertension and a principle investigator for several projects supported by the National Natural Science Foundation of China and the Shanghai Municipal Natural Science Foundation. She received training in molecular genetics, bioinformatics and epidemiology at the Chinese National Human Genome Center and at the Framingham Heart Study as a NIH/NHLBI visiting researcher. Dr. Zhang has received Shanghai Subject Chief Scientist and 60 publications in journals such as Nat Genet, Circ Cardiovasc Genet, Hum Mol Genet, 4 book chapters, and has 3 China patents. Dr. Zhang obtained her MD and PhD from Shanghai Jiaotong University School of Medicine, specialized in cardiology.

Positions